Our firm Expertise Our people News Careers Blogs Our stories Coronavirus (COVID-19) Contact Alumni 中国事务部 Privacy/cookie policy English menu search How can we help you? Search close Breadcrumbs Expertise Industries Life Sciences Life Sciences We advise national and international clients in the pharmaceutical, biotechnology and medical devices sectors, from start-ups to market leaders. We act both behind the scenes and in court where necessary. Thanks to our extensive experience and active participation in many large professional organisations (for example, HollandBio, Bio.be and Flandersbio) we have built a powerful network and a comprehensive knowledge base of the sector. We are a co-founder of the Belgian Master Class in Biotechnology, run by the Institute of Pharmaceutical Business Administration. Our lawyers publish and speak regularly on such subjects as handling regulation, competition, IP and financing in the pharmaceutical, biotechnical and medical devices sectors. NautaDutilh's Life Sciences team takes a holistic approach and is composed of associates from various practice groups (including regulatory, IP, public procurement, privacy, competition, M&A and finance specialists). This enables us to provide the full range of advisory, litigation and transactional services, tailored to meet our clients' needs. Read more Full-service approach Our experience and full-service approach enable us to tailor our services to meet the needs of our life sciences clients at all stages of their product and business cycles: from company start-up, financing rounds and investment arrangements through to acquisition by listed companies or another form of exit such as an IPO. For business operations we assist with contracting (including licensing), regulatory work, patent issues, risk management and compliance. As a result of our dedication and attention to the life sciences sector, we are now widely recognised among industry players as one of the go-to full- service advisers in the Benelux. Highlighted work The Life Sciences team boasts the largest Dutch pharma deal (in size) ever: AstraZeneca's up to USD 7 billion acquisition of Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US. It advised ThermoFisher on its acquisition of Patheon, Mylan on its USD 22 billion merger with Pfizer's spin-out Upjohn, Sanofi on its acquisition of Ablynx and Janssen/Johnson&Johnson on its collaboration with argenx. Read more In addition, the team has worked on various high-level corporate projects (e.g. the integration of Pfizer's and Wyeth's businesses) and a number of IPOs and other capital market transactions: and it has also performed ongoing venture capital work concerning various successful biotech, pharma, agrotech and medical devices companies. At the same time, it provides high-end regulatory and litigation services with regard to product launches and distribution, advertising, clinical trials, generic entry, patent litigation and product liability issues, to name a few. Meet the team leads see the whole team Ruud Smits Partner, Netherlands +31 20 71 71 680 Ruud.Smits@nautadutilh.com Life Sciences Corporate / M&A Private Equity Telecom Media & Technology view details Florence Verhoestraete Partner, Brussels +32 2 566 8452 Florence.Verhoestraete@nautadutilh.com Intellectual Property Healthcare Litigation Life Sciences Agri & Food Food & Consumer Products view details Vincent Wellens Partner, Luxembourg +352 26 12 29 34 Vincent.Wellens@nautadutilh.com Intellectual Property Information & Communication Technology Telecom Media & Technology Competition Privacy & Data Protection Outsourcing Regulatory Litigation Public Procurement Law Cartel Damages Financial Institutions Life Sciences Payment Services view details Rebecca Runa Pinto - Noome Partner, New York +1 212 218 4325 Rebecca.Pinto@nautadutilh.com Corporate / M&A Private Equity Life Sciences Telecom Media & Technology view details Related articles Deal or case news NautaDutilh assists CureVac on the private financing round, IPO and private placement On 14 August 2020, CureVac NV launched a successful IPO on the Nasdag Global Market, raising USD 213 million. The company raised a further USD 118 million in a private placement and recently comple... 14-08-2020 Paul (P.C.S.) van der Bijl Nina (C.E.) Kielman Dewi (D.J.) Walian CJEU rules that free samples of OTC medicinal products can be provided to pharmacists Read more On this page Introduction Highlighted work Meet the team leads Related articles International Law Firm Amsterdam Brussels London Luxembourg New York Rotterdam youtube linkedin twitter User terms General conditions Legal information Responsible Disclosure Register of legal areas Managing partners Cookie notice Our website only uses cookies when you play video content. Video content is streamed from Vimeo. Our website does not use tracking cookies and/or third party cookies when you do not play video content. Please read the privacy/cookie policy for more information.